Merck & Co., Inc.  

(Public, NYSE:MRK)   Watch this stock  
Find more results for MRK
56.05
+0.03 (0.05%)
Real-time:   2:46PM EST
NYSE real-time data - Disclaimer
Currency in USD
Range 55.75 - 56.37
52 week 53.63 - 66.80
Open 56.23
Vol / Avg. 9.87M/12.46M
Mkt cap 152.87B
P/E 54.34
Div/yield 0.48/3.43
EPS 1.03
Shares 2.73B
Beta 0.76
Inst. own 76%
Feb 2, 2018
Q4 2017 Merck & Co Inc Earnings Release - 9:30AM EST - Add to calendar
Feb 2, 2018
Q4 2017 Merck & Co Inc Earnings Call - 8:00AM EST - Add to calendar
Dec 7, 2017
Merck & Co Inc at Citi Global Healthcare Conference
Nov 7, 2017
Merck & Co Inc at Credit Suisse Healthcare Conference - Webcast
Oct 27, 2017
Q3 2017 Merck & Co Inc Earnings Release
Oct 27, 2017
Q3 2017 Merck & Co Inc Earnings Call - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '17) 2016
Net profit margin -0.49% 9.90%
Operating margin 1.10% 12.24%
EBITD margin - 58.35%
Return on average assets -0.22% 4.00%
Return on average equity -0.58% 9.25%
Employees 68,000 -
CDP Score - B

Address

2000 Galloping Hill Rd
KENILWORTH, NJ 07033-1310
United States - Map
+1-908-7404000 (Phone)
+1-908-4231987 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services and Alliances. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells its human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers, such as health maintenance organizations, pharmacy benefit managers and other institutions. Vaccine products consist of preventive pediatric, adolescent and adult vaccines, primarily administered at physician offices.

Officers and directors

Kenneth C. Frazier Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Robert M. Davis Chief Financial Officer, Executive Vice President
Age: 50
Bio & Compensation  - Reuters
Michael J. Holston Executive Vice President, General Counsel
Age: 54
Bio & Compensation  - Reuters
Mirian M. Graddick-Weir Executive Vice President - Human Resources
Age: 62
Bio & Compensation  - Reuters
Sanat Chattopadhyay Executive Vice President and President - Merck Manufacturing Division
Age: 57
Bio & Compensation  - Reuters
Richard R. DeLuca Jr. Executive Vice President, President - Merck Animal Health
Age: 54
Bio & Compensation  - Reuters
Julie Louise Gerberding M.D. Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy and Population Health
Age: 61
Bio & Compensation  - Reuters
Roger M. Perlmutter M.D. Ph.D. Executive Vice President, President - Merck Research Laboratories
Age: 65
Bio & Compensation  - Reuters
Adam H. Schechter Executive Vice President, President - Global Human Health
Age: 52
Bio & Compensation  - Reuters
Rita A. Karachun Senior Vice President Finance - Global Controller
Age: 53
Bio & Compensation  - Reuters